Table 2. Comparison of the incidence of hypothyroidism among initially diagnosed breast cancer patients, breast benign diseases patients and patients during chemotherapy.
Groups | case | Age | Incidence of clinical hypothyroidism | Incidence of subclinical hypothyroidism | Incidence of Low T3 syndrome | Incidence of total hypothyroidism |
---|---|---|---|---|---|---|
Initially diagnosed BC patients | 726 | 51.03±10.98 | 2.2%(16/726) | 20.25% (147/726) | 6.2% (45/726) | 28.65% (208/726) |
BBD patients | 336 | 44.5±12.23* | 2.38% (8/336) | 24.4% (82/336) | 5.95% (20/336) | 32.74% (110/336) |
during chemotherapy | 153 | 49.03±8.50* | 2.61% (4/153) | 21.57% (33/153) | 6.54% (10/153) | 30.72% (47/153) |
*p<0.05 vs. initially diagnosed breast cancer.